Overview

Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. In collaboration with Sanofi, the company has developed numerous medications targeting a range of conditions.

Therapeutic areas

FDA compliance signals

11 FDA enforcement records linked to this company.

  • recall — Class II2024-06-05

    Lack of Assurance of Sterility: Complaints of syringe breakage

  • recall — Class II2024-05-08

    Lack of Assurance of Sterility: Complaints of syringe breakage

  • 4832021-10-25

    No written record of investigation

  • 4832021-10-25

    Procedures for sterile drug products

  • 4832021-10-25

    Validation lacking for sterile drug products

  • 4832021-10-25

    Cleaning System

  • 4832021-10-25

    Investigations of discrepancies, failures

  • 4832019-10-18

    Procedures not in writing, fully followed

  • 4832016-08-19

    Procedures not in writing, fully followed

  • 4832014-06-13

    Procedures not in writing, fully followed

  • 4832013-05-24

    Procedure Deviations Recorded and Justified

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.